|
|
Article: Issue Of Patenting Genes Still Troubling For Biotech Industry.(Conference notes)
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Washington Editor
WASHINGTON - Some scientists and intellectual property attorneys worry that existing laws associated with gene patenting may actually stifle research rather than serve the intended purpose of encouraging it.
That's on this side of the pond. On the other side of the pond, Tim Powell, a partner with Bristows law firm in London, told an audience at BIO 2003, the Biotechnology Industry Organization's annual conference, that in certain cases the British have characterized genome patenting as revolting, an invasion of privacy or a method that allows many large companies to control important patents.
If you're big pharma or big ...